INSIGHTS ON CLINICAL TRIAL DESIGN
-
4 Proven Strategies To Optimize Patient Enrollment, Avoid Rescue Trials
Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.
-
Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints
By embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.
-
Tracking Functional Capacity To Advance Neuromuscular Disease Research
This presentation introduces a dual-endpoint approach to monitoring neuromuscular disease progression through two high-centile digital measures.
-
Simultaneous Submissions And Managing Multiple Regulatory Pathways
Global regulators are increasingly aligned, creating new opportunities for sponsors to pursue near-simultaneous submissions across major markets
-
Balancing Patient Centricity With Complexity In Cancer Trials10/28/2025
By bringing clinical research closer to where patients live and receive care, sponsors and CROs can expand reach, reduce travel burdens, and engage populations historically underrepresented in cancer studies.
-
Stop Guessing On Trial Feasibility: Simulating Patient Recruitment With AI5/28/2026
Simulate enrollment, endpoints, and criteria with integrated data and synthetic populations to test protocol feasibility early — refining design and reducing recruitment and regulatory risks.
-
High Density, Low Availability: Rethinking Ophthalmic Trial Readiness4/16/2025
The adoption of mobile ophthalmic solutions and collaboration with specialized vendors is recommended to ensure trial consistency and reach underserved regions.
-
Why Amendments Break Trials and How Elosity R3 Fixes It7/31/2026
Protocol amendments are inevitable. The challenge is managing them without disrupting trial execution.
-
Avoiding The Gotchas: RTSM Build Tips From A Seasoned PM3/25/2026
Small protocol details can create outsized challenges when definitions are unclear or when integrations aren’t planned early.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
-
Accelerate obesity research with specialized expertise in GLP-1 trials. Our approach ensures rapid enrollment, high participant retention, and clean data through a patient-centered model.
-
Modernize research pharmacy operations with digital workflows that reduce manual effort, improve compliance, strengthen audit readiness, and help sites support more protocols with confidence.
-
Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.
-
Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.